Concepedia
Statistics
Publications
9
Citations
547
H-Index
Active since
1971
Affiliations
Novartis (Switzerland)(Current)
University of Münster
KU Leuven
J. Brüggen is an author at Novartis (Switzerland) specializing in oncology, life sciences, and neoplasia.
Publications per year
1971–2010
Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues.
G. Zwadlo, J. Brüggen, Gerold Gerhards et al. · PubMed · 1988 · 276 citations · Full text
Life Sciences, Immunology, Molecular Biology +12
Restin: a novel intermediate filament‐associated protein highly expressed in the Reed‐Sternberg cells of Hodgkin's disease.
Graeme Bilbe, Jan Delabie, J. Brüggen et al. · The EMBO Journal · 1992 · 79 citations · Full text
Life Sciences, Cancer Biology, Cell Biology +7
A tumor‐associated antigen expressed in melanoma cells with lower malignant potential
L. Suter, J. Brüggen, E.-B. Bröcker et al. · International Journal of Cancer · 1985 · 45 citations
Medicine, Oncology, Pathology +15
Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma
Jan Delabie, R Shipman, J. Brüggen et al. · Blood · 1992 · 44 citations · Full text
Medicine, Cell Biology, Oncology +11
Tumor angiogenic activity (TAA) production in vitro and growth in the nude mouse by human malignant melanoma
W. Stenzinger, J. Brüggen, E. Macher et al. · European Journal of Cancer and Clinical Oncology · 1983 · 39 citations
Medicine, Cancer Biology, Oncology +15
1–5 of 9